Literature DB >> 22234688

Emerging role of serpinE2/protease nexin-1 in hemostasis and vascular biology.

Marie-Christine Bouton1, Yacine Boulaftali, Benjamin Richard, Véronique Arocas, Jean-Baptiste Michel, Martine Jandrot-Perrus.   

Abstract

Serine protease inhibitors, termed serpins, are key regulators in many biologic events. Protease nexin-1 (PN-1) is a serpin that is barely detectable in plasma but found in many organs and produced by most cell types, including monocytes, platelets, and vascular cells. It has a large inhibition spectrum because it is the most efficient tissue inhibitor of thrombin but also a powerful inhibitor of plasminogen activators and plasmin. It has a high affinity for glycosaminoglycans, such as heparan sulfates, which potentiate its activity toward thrombin and target it to the pericellular space. PN-1 has been previously largely described as a crucial regulator of the proteolytic activity in nerves and of central and peripheral nervous system function. In contrast, little was known about its involvement in hemostasis and vascular biology. This article reviews recent data underlining its emerging role as a key factor in the responses of vessels to injury. Indeed, studies of PN-1-deficient mice have established important antithrombotic and antifibrinolytic properties of this serpin that have heretofore gone unrecognized. The roles of PN-1 in the areas of hemostasis and thrombosis summarized here provide insights that may allow the development of drugs and treatment strategies to prevent or limit thrombotic disorders.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22234688     DOI: 10.1182/blood-2011-10-387464

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

1.  Serpine2 deficiency results in lung lymphocyte accumulation and bronchus-associated lymphoid tissue formation.

Authors:  Siva Kumar Solleti; Sorachai Srisuma; Soumyaroop Bhattacharya; Javier Rangel-Moreno; Kaiser M Bijli; Troy D Randall; Arshad Rahman; Thomas J Mariani
Journal:  FASEB J       Date:  2016-04-08       Impact factor: 5.191

Review 2.  From genetics to response to injury: vascular smooth muscle cells in aneurysms and dissections of the ascending aorta.

Authors:  Jean-Baptiste Michel; Guillaume Jondeau; Dianna M Milewicz
Journal:  Cardiovasc Res       Date:  2018-03-15       Impact factor: 10.787

3.  Whole-exome sequencing in evaluation of patients with venous thromboembolism.

Authors:  Eun-Ju Lee; Daniel J Dykas; Andrew D Leavitt; Rodney M Camire; Eduard Ebberink; Pablo García de Frutos; Kavitha Gnanasambandan; Sean X Gu; James A Huntington; Steven R Lentz; Koen Mertens; Christopher R Parish; Alireza R Rezaie; Peter P Sayeski; Caroline Cromwell; Noffar Bar; Stephanie Halene; Natalia Neparidze; Terri L Parker; Adrienne J Burns; Anne Dumont; Xiaopan Yao; Cassius Iyad Ochoa Chaar; Jean M Connors; Allen E Bale; Alfred Ian Lee
Journal:  Blood Adv       Date:  2017-06-29

4.  Protease nexin-1 regulates retinal vascular development.

Authors:  Sonia Selbonne; Deborah Francois; William Raoul; Yacine Boulaftali; Florian Sennlaub; Martine Jandrot-Perrus; Marie-Christine Bouton; Véronique Arocas
Journal:  Cell Mol Life Sci       Date:  2015-06-25       Impact factor: 9.261

5.  Endothelial PAI-1 (Plasminogen Activator Inhibitor-1) Blocks the Intrinsic Pathway of Coagulation, Inducing the Clearance and Degradation of FXIa (Activated Factor XI).

Authors:  Cristina Puy; Anh T P Ngo; Jiaqing Pang; Ravi S Keshari; Matthew W Hagen; Monica T Hinds; David Gailani; András Gruber; Florea Lupu; Owen J T McCarty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-05-23       Impact factor: 8.311

6.  Differentially expressed genes in autosomal dominant osteopetrosis type II osteoclasts reveal known and novel pathways for osteoclast biology.

Authors:  Amélie E Coudert; Andrea Del Fattore; Céline Baulard; Robert Olaso; Corinne Schiltz; Corinne Collet; Anna Teti; Marie-Christine de Vernejoul
Journal:  Lab Invest       Date:  2013-12-16       Impact factor: 5.662

7.  Platelet anticoagulant proteins: Modulators of thrombosis propensity within a procoagulant cell.

Authors:  Amy E Siebert; Alan E Mast
Journal:  J Thromb Haemost       Date:  2020-07-30       Impact factor: 5.824

8.  Multivariate Genome-wide Association Analysis of a Cytokine Network Reveals Variants with Widespread Immune, Haematological, and Cardiometabolic Pleiotropy.

Authors:  Artika P Nath; Scott C Ritchie; Nastasiya F Grinberg; Howard Ho-Fung Tang; Qin Qin Huang; Shu Mei Teo; Ari V Ahola-Olli; Peter Würtz; Aki S Havulinna; Kristiina Santalahti; Niina Pitkänen; Terho Lehtimäki; Mika Kähönen; Leo-Pekka Lyytikäinen; Emma Raitoharju; Ilkka Seppälä; Antti-Pekka Sarin; Samuli Ripatti; Aarno Palotie; Markus Perola; Jorma S Viikari; Sirpa Jalkanen; Mikael Maksimow; Marko Salmi; Chris Wallace; Olli T Raitakari; Veikko Salomaa; Gad Abraham; Johannes Kettunen; Michael Inouye
Journal:  Am J Hum Genet       Date:  2019-10-31       Impact factor: 11.025

9.  Protease nexin-1 deficiency increases mouse hindlimb neovascularisation following ischemia and accelerates femoral artery perfusion.

Authors:  Sonia Selbonne; Celina Madjene; Benjamin Salmon; Yacine Boulaftali; Marie-Christine Bouton; Véronique Arocas
Journal:  Sci Rep       Date:  2021-06-28       Impact factor: 4.379

10.  Genes regulated in metastatic osteosarcoma: evaluation by microarray analysis in four human and two mouse cell line systems.

Authors:  Roman Muff; Ram Mohan Ram Kumar; Sander M Botter; Walter Born; Bruno Fuchs
Journal:  Sarcoma       Date:  2012-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.